Author | Subject | Intervention(Point/Method) | Period | Results after treatment |
Cheng HC 14) | n=73(aged6-12) | Exp(n=20) | 0.125%Atropine+神門,心,目1,目2/Ear acu | >6mths | Myopic progression(D)-0.41<-0.66,AL elongation(㎜/year):0.24/0.32ACE elongation(mm/year):0.076>0.023, IOP decrement(㎜Hg/year):−1.01>−0.13, Auricular acupoint stimulation in combination with low-concentration topical atropine was beneficial for myopia control. |
Con(n=53) | 0.125%Atropine |
Liang CK 20) | n=71(school aged) | Exp1(n=22) | 0.25%Atropine | >6mths | Myopia progression(diopter change/year):No significant difference between Exp2(0.15±0.15) and Exp3(0.21±0.23). Reduced myopia progression in Exp3 compared to Exp1(p<0.05)AL elongation:No statistical difference among these 3 groups |
Exp2(n=23) | 0.5%Atropine |
Exp3(n=26) | 0.25%Atropinge+神門,腎,肝,脾,心,皮質下,目1,目2/Ear acu |